Skip to content

Author

Laura Szalewska

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

GUT MICROBIOTA AND PHARMACOLOGICAL TREATMENT RESPONSE IN OBESITY: IMPLICATIONS FOR PERSONALIZED MEDICINE

Obesity is a chronic, multifactorial metabolic disease associated with significant morbidity, mortality, and increasing global prevalence. In recent years, the gut microbiota has emerged as an important regulator of host metabolism, energy homeostasis, inflammation, and appetite control (Gomes et al., 2018; Geng et al....

Julia Burtowicz, Magda Kossmann, Laura Szalewska et al. · 0 citations
Review Open access Aug 2026

STRAIN-SPECIFIC EFFECTS OF PROBIOTICS IN GASTROESOPHAGEAL REFLUX DISEASE: A COMPREHENSIVE REVIEW

Gastroesophageal reflux disease (GERD) is one of the most prevalent gastrointestinal disorders worldwide and represents a significant burden on healthcare systems due to its high prevalence, chronic course, and impact on patients’ quality of life. Although proton pump inhibitors (PPIs) remain the cornerstone of GERD tr...

Izabela Kazubek-Fuksiewicz, Magda Kossmann, Amin Abdulgater et al. · 0 citations
Review Open access Sep 2026

THE EVOLVING LANDSCAPE OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE: FROM PATHOGENESIS TO PRECISION MEDICINE

Non-Alcoholic Fatty Liver Disease (NAFLD), recently reclassified as Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), represents one of the most significant challenges in modern hepatology and metabolic medicine (Rinella et al., 2023). This paper examines the evolution of the disease's nomenclature and...

Magda Kossmann, Laura Szalewska, Paulina Osuch-Tomaszewska et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.